MedTrace Logo

Kidney Histopathology After COVID-19 and SARS-CoV-2 Vaccination

NCT05043168 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2022-05-19

No results posted yet for this study

Summary

The study aims to summarize kidney histopathological findings in patients with coronavirus disease 2019 (COVID-19) and post-severe acute respiratory syndrome-coronavirus-type 2 (SARS-CoV-2) vaccination.

Conditions

  • Covid19
  • Vaccination Reaction

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER

  • University of Giessen

    lead OTHER

Principal Investigators

  • Thorsten Wiech, MD · Nephropathology Section, Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-18
Primary Completion
2021-12-31
Completion
2022-05-17

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05043168 on ClinicalTrials.gov